(Q80608577)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15389253%20AND%20SRC:MED&resulttype=core&format=json

2 January 2020

title

ImmunoCyt/uCyt+ improves the sensitivity of urine cytology in patients followed for urothelial carcinoma (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15389253%20AND%20SRC:MED&resulttype=core&format=json

2 January 2020

1 reference

Bernard Têtu

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15389253%20AND%20SRC:MED&resulttype=core&format=json

2 January 2020

Rabi Tiguert

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15389253%20AND%20SRC:MED&resulttype=core&format=json

2 January 2020

François Harel

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15389253%20AND%20SRC:MED&resulttype=core&format=json

2 January 2020

Yves Fradet

series ordinal

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15389253%20AND%20SRC:MED&resulttype=core&format=json

2 January 2020

publication date

1 January 2005

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15389253%20AND%20SRC:MED&resulttype=core&format=json

2 January 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15389253%20AND%20SRC:MED&resulttype=core&format=json

2 January 2020

volume

18

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15389253%20AND%20SRC:MED&resulttype=core&format=json

2 January 2020

issue

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15389253%20AND%20SRC:MED&resulttype=core&format=json

2 January 2020

page(s)

83-89

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15389253%20AND%20SRC:MED&resulttype=core&format=json

Recurrence, progression and survival in bladder cancer. A retrospective analysis of 232 patients with greater than or equal to 5-year follow-up

2 January 2020

cites work

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3800262

7 January 2021

Current status of urinary cytology in the evaluation of bladder neoplasms

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3800262

7 January 2021

Immunocyt: a new tool for detecting transitional cell cancer of the urinary tract

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3800262

7 January 2021

The World Health Organization/International Society of Urological Pathology consensus classification of urothelial (transitional cell) neoplasms of the urinary bladder. Bladder Consensus Conference Committee

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3800262

7 January 2021

ImmunoCyt a useful method in the follow-up protocol for patients with urinary bladder carcinoma

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3800262

7 January 2021

Role of uCyt+ in the detection and surveillance of urothelial carcinoma

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3800262

7 January 2021

Improved detection of urothelial carcinomas with fluorescence immunocytochemistry (uCyt+ assay) and urinary cytology: results of a French Prospective Multicenter Study

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3800262

7 January 2021

Diagnostic efficacy of the ImmunoCyt test to detect superficial bladder cancer recurrence

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3800262

7 January 2021

Microsatellite analysis--DNA test in urine competes with cystoscopy in follow-up of superficial bladder carcinoma: a phase II trial

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3800262

7 January 2021

Detection of upper urinary tract transitional cell carcinoma with ImmunoCyt: a preliminary report

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3800262

7 January 2021

Immunocyt test improves the diagnostic accuracy of urinary cytology: results of a French multicenter study

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3800262

7 January 2021

Effect of intravesical instillation on performance of uCYT+ test

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3800262

7 January 2021

Comparison of screening methods in the detection of bladder cancer

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3800262

7 January 2021

Improved detection of recurrent bladder cancer using the Bard BTA stat Test

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3800262

7 January 2021

Usefulness of the BTA STAT Test for the diagnosis of bladder cancer

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3800262

7 January 2021

Comparison of the bard bta test with voided urine and bladder wash cytology in the diagnosis and management of cancer of the bladder

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3800262

7 January 2021

Comparison of the Bard Trak test with voided urine cytology in the diagnosis and follow-up of bladder tumors

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3800262

7 January 2021

Comparison of cytology and nuclear matrix protein 22 for the detection and follow-up of bladder cancer

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3800262

7 January 2021

Comparative evaluation of the BTAstat test, NMP22, and voided urine cytology in the detection of primary and recurrent bladder tumors

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3800262

7 January 2021

Comparison of two qualitative assays, the UBC rapid test and the BTA stat test, in the diagnosis of urothelial cell carcinoma of the bladder

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3800262

7 January 2021

BTA stat and BTA TRAK: A comparative evaluation of urine testing for the diagnosis of transitional cell carcinoma of the bladder

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3800262

7 January 2021

Urinary BTA-stat, BTA-trak and NMP22 in surveillance after TUR of recurrent superficial transitional cell carcinoma of the bladder

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3800262

7 January 2021

Clinical evaluation of the BTA TRAK assay and comparison to voided urine cytology and the Bard BTA test in patients with recurrent bladder tumors. The Multi Center Study Group

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3800262

7 January 2021

Evaluation of NMP22 in the detection of transitional cell carcinoma of the bladder

1 reference

https://api.crossref.org/works/10.1038%2FMODPATHOL.3800262

7 January 2021